PI3K Signaling in Tissue Hyper-Proliferation: From Overgrowth Syndromes to Kidney Cysts

被引:37
作者
De Santis, Maria Chiara [1 ]
Sala, Valentina [1 ]
Martini, Miriam [1 ]
Ferrero, Giovanni Battista [2 ]
Hirsch, Emilio [1 ]
机构
[1] Univ Torino, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy
[2] Univ Torino, Dept Publ Hlth & Pediat, I-10126 Turin, Italy
来源
CANCERS | 2017年 / 9卷 / 04期
关键词
PI3K; mTOR; proliferation; overgrowth syndrome; polycystic kidney disease; TUBEROUS SCLEROSIS COMPLEX; HAMARTOMA TUMOR SYNDROME; PHOSPHOINOSITIDE; 3-KINASES; PIK3CA(H1047R) MUTATION; ACTIVATING MUTATIONS; ONCOGENIC MUTATIONS; CLOVES SYNDROME; EPIDERMAL-NEVI; PIK3CA CAUSE; DISEASE;
D O I
10.3390/cancers9040030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The members of the PhosphoInositide-3 Kinase (PI3K) protein family are well-known regulators of proliferative signals. By the generation of lipid second messengers, they mediate the activation of AKT/PKB (AKT) and mammalian Target Of Rapamycin (mTOR) pathways. Although mutations in the PI3K/AKT/mTOR pathway are highly characterized in cancer, recent evidence indicates that alterations in the proliferative signals are major drivers of other diseases such as overgrowth disorders and polycystic kidney disease. In this review, we briefly summarize the role of the PI3K/AKT/mTOR pathway in cell proliferation by comparing the effect of alterations in PI3K enzymes in different tissues. In particular, we discuss the most recent findings on how the same pathway may lead to different biological effects, due to the convergence and cooperation of different signaling cascades.
引用
收藏
页数:11
相关论文
共 75 条
  • [1] New insights into the generation and role of de novo mutations in health and disease
    Acuna-Hidalgo, Rocio
    Veltman, Joris A.
    Hoischen, Alexander
    [J]. GENOME BIOLOGY, 2016, 17
  • [2] Inactivation of the Class II PI3K-C2β Potentiates Insulin Signaling and Sensitivity
    Alliouachene, Samira
    Bilanges, Benoit
    Chicanne, Gaetan
    Anderson, Karen E.
    Pearce, Wayne
    Ali, Khaled
    Valet, Colin
    Posor, York
    Low, Pei Ching
    Chaussade, Claire
    Scudamore, Cheryl L.
    Salamon, Rachel S.
    Backer, Jonathan M.
    Stephens, Len
    Hawkins, Phill T.
    Payrastre, Bernard
    Vanhaesebroeck, Bart
    [J]. CELL REPORTS, 2015, 13 (09): : 1881 - 1894
  • [3] Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome
    Alomari, Ahmad I.
    [J]. CLINICAL DYSMORPHOLOGY, 2009, 18 (01) : 1 - 7
  • [4] Recent advances in RASopathies
    Aoki, Yoko
    Niihori, Tetsuya
    Inoue, Shin-ichi
    Matsubara, Yoichi
    [J]. JOURNAL OF HUMAN GENETICS, 2016, 61 (01) : 33 - 39
  • [5] Cystogenesis and elongated primary cilia in Tsc1-deficient distal convoluted tubules
    Armour, Eric A.
    Carson, Robert P.
    Ess, Kevin C.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2012, 303 (04) : F584 - F592
  • [6] Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes
    Bhagirath, Divya
    Zhao, Xiangshan
    West, William W.
    Qiu, Fang
    Band, Hamid
    Band, Vimla
    [J]. ONCOTARGET, 2015, 6 (11) : 9018 - 9030
  • [7] Biesecker LG, 1998, AM J MED GENET, V79, P311, DOI 10.1002/(SICI)1096-8628(19981002)79:4<311::AID-AJMG14>3.0.CO
  • [8] 2-U
  • [9] Boon LM, 2015, PLAST RECONSTR SUR S, V136, P38
  • [10] High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome
    Bubien, Virginie
    Bonnet, Francoise
    Brouste, Veronique
    Hoppe, Stephanie
    Barouk-Simonet, Emmanuelle
    David, Albert
    Edery, Patrick
    Bottani, Armand
    Layet, Valerie
    Caron, Olivier
    Gilbert-Dussardier, Brigitte
    Delnatte, Capucine
    Dugast, Catherine
    Fricker, Jean-Pierre
    Bonneau, Dominique
    Sevenet, Nicolas
    Longy, Michel
    Caux, Frederic
    [J]. JOURNAL OF MEDICAL GENETICS, 2013, 50 (04) : 255 - 263